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On substituting r = 7, we obtain the expression given earlier in
the paper.
It is easy to show that w(t0) is a maximum when t0 = (s   1) 
t/(r   2). Substituting r = 7 and s = 1, the maximum
weight occurs when t0 = 0; this means that if p1 changes with
time, the incidence rate at any given age is proportional to the
weighted mean of p1 over the whole period of exposure, the
weight being greatest near the beginning of the period.
Similarly, substituting r = 7 and s = 2, 3, 4, 5 and 6, we find that
the maximum weight occurs when t0 = t/5, 2t/5, 3t/5, 4t/5 and
t, respectively.
In applying this theory to the data of Lenowitz and Graham
(1946) and Shrek and Lenowitz (1947), we must assume
that the distribution of the ages at circumcision in the
patients without penile cancer is representative of that in the
population from which the penile cancer patients have been
drawn; on this assumption the data of Table II provide valid
estimates of the relative risks of penile cancer in the four
groups. We shall ignore the variation in age amongst
the patients, and consider the expected incidence of penile
cancer at t = 53 years (the average age of all the patients
referred to in Table II). We consider a theoretical model in
which  r = 7 and s = 1; and in which p1 is constant for an
uncircumcised person, but becomes zero as soon as
circumcision is carried out. For each of the four age
groups shown in Table II, we assume, for simplicity, that
circumcision takes place at the mid-point of the group, i.e. at 3,
11.5, 26.5 and 44.5 years, respectively. From the theoretical
result proved above, the incidence at t = 53 is proportional
to the weighted mean of p1 over the period of exposure,
the weight corresponding to exposure at age t0 being 
(53   t0)5. The incidences for the four groups are therefore
proportional to
where T is the mid-point of each group. Using the values of T
given above, the incidences are found to be proportional to
0.30, 0.77, 0.98 and 1.00.
A more realistic assumption would be that the men in the first
group were almost all circumcised within the first few weeks of
life; on this assumption the theoretical risk for this group would
clearly be very small.
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Commentary: Mathematical models of cancer
progression and epidemiology in the age of
high throughput genomics
Steven A Frank
The major principles of genetics and evolution were developed
before the structure of DNA was discovered in 1953. Darwin got
pretty much everything right about evolution, despite his
mistaken views on genetics. After the rediscovery of Mendel’s
theory, Fisher, Wright, and Haldane worked out the mathe-
matical principles of mutation, selection, and evolutionary
genetics during the first half of the 20th century. The
spectacular accomplishments of modern molecular biology have
greatly enriched understanding of genetics and evolution.
However, the foundational principles of evolution and
adaptation from the pre-molecular era remain the guidelines by
which we interpret why biology appears as it does.
Perhaps Armitage and Doll’s1 paper marks the same sort of
divide in cancer research. Their paper laid out foundational
principles of cancer progression and epidemiology in
Department of Ecology and Evolutionary Biology, University of California,
Irvine, CA 92697-2525 USA. E-mail: safrank@uci.edumathematical form long before we knew about the molecular
basis of somatic mutation and the key roles of genes such as p53
and APC.
The puzzle faced by Armitage and Doll was set out by Fisher
and Hollomon2 and Nordling,3 who used epidemiological data
to infer that cancer incidence increases with approximately the
sixth power of age. The pioneers of genetics and evolution faced
the same sort of problem: how can one use easily observed
patterns in populations to infer the underlying dynamical
processes that give rise to those patterns? In the case of cancer,
what can be said about the dynamical processes of progression
within individuals that would explain the aggregate patterns of
epidemiology observed in populations?
Fisher and Hollomon recognized that the rate of cancer
occurrence would rise with the nth power of age if trans-
formation required n   1 independent steps. The argument is
roughly as follows. Suppose each step happens at a rate of u per
year, where u is a small rate. The probability of any step having
happened after t years is ut. At age t, the probability that n of the
steps has occurred is (ut)n, and the rate at which the final step
happens is u, so the rate of occurrence at time t is proportional
to un 1tn. For example, if n   1   2, then the probability that
one step has occurred at time t is ut, and the rate at which the
final step happens is u, so the rate at time t is proportional to u2t.
Fisher and Hollomon suggested that about seven cells had to
be transformed independently. This would give the observed
rate of change with age. However, Armitage and Doll1 pointed
out that if transformation happens by one step in each of several
independent cells, then tumour incidence should increase with
about the sixth power of carcinogen dose. Instead, incidence
rises approximately linearly with dose, rejecting the multiple
cell hypothesis.
Nordling proposed that approximately seven successive steps
must occur over the history of a transformed cell lineage.
Armitage and Doll1 noted that if the steps tend to occur in a
particular order, this theory explains the rise in incidence with
the six power of age, the linear relation between carcinogen
dose and incidence, and the long time delay that usually occurs
between carcinogen exposure and transformation.
Armitage and Doll followed this introduction with an analysis
of incidence curves for cancers of various tissues and a
discussion of how to think about the mathematical theory in
terms of the biology. Several incidence curves matched the
theory with about seven steps and constant rates of transition.
Other curves failed to fit the simple theory, and may possibly be
explained by fewer steps, with the rates of transition between
steps increasing with age. Armitage and Doll emphasized that
the steps represent stages in transformation, each step separated
from the next stage by some rate-limiting event. Those events
might be mutations, but other factors in transformation could
also serve as rate-limiting events.
An extensive mathematical literature has refined this theory
and fit various models to more detailed sets of data. Most
discussions of cancer progression depend in some way on a
multistage theory of progression, although opinions vary widely
about the nature of those steps and which biological processes
may be most important.
Returning to my opening theme, Armitage and Doll’s
multistage theory developed the major concepts for how to
think about incidence, carcinogenesis, and progression. They
did this while almost nothing was known about the genetic,
molecular, and cellular mechanisms of progression. In this
current age of high throughput genomics and the promise of
soon knowing much about the mechanistic details of
progression, will Armitage and Doll’s insights continue to play a
role in shaping the subject, or is this an historical footnote with
little consequence for modern studies of cancer?
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Figure 1 Age-specific incidence and acceleration of cancer for
different tissues. (a) Age-specific incidence for four adult-onset
epithelial cancers. (b, c) Age-specific log-log acceleration, which are
slopes of the plots in (a) at different ages. All data from the SEER
database (www.seer.cancer.gov) using the nine SEER registries, year of
diagnosis 1992–2000. Breast cancer data for all females, colorectal
cancer for all males, lung cancer for all males, and prostate cancer for
white males. Reprinted from ref. 4.
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prostateI believe that extensions of the Armitage-Doll mathematical
theory will play an important role in the future of cancer
studies. I give two examples of how this might occur.
The first example moves from detailed genetic observations
up toward a full understanding of the dynamic processes that
drive cancer progression. A typical tumour cell has a large
number of genetic changes throughout its genome when
compared with the normal, ancestral cell from which the
tumour cell evolved. Many tumour lineages suffer periods of
chromosomal instability that cause major karyotypic changes.
Probably several of those karyotypic changes play an important
role in transformation, whereas many other genetic changes
have little or no effect on the success of tumour lineages.
Perhaps the most important goal of high throughput genetic
analysis will be to determine which changes matter and which
are less important. The definition of ‘which changes matter’
should be a quantitative, dynamical one. How do particular
genetic changes accelerate or decelerate progression? How does
the order of changes and the particular combination of changes
affect rates of progression? Mathematical modelling will be
important in connecting the genetic changes to the associated
biochemical pathways and to the consequences for cellular birth
and death rates. Those new mathematical models may become
rather detailed and complex, but to be useful they must be
brought back to the simple mathematical structure of Armitage
and Doll—the stages of progression, the rates of change
between stages, and the consequences for the rate of incidence
in populations.
The second example works in the other direction, from
simple mathematical models of progression like Armitage and
Doll’s to testable hypotheses about the nature of the underlying
genetic and cellular mechanisms that drive progression. I
recently examined the SEER database (www.seer.cancer.gov),4
a more detailed data set on cancer incidence than was available
to Armitage and Doll. Figure 1 shows four of the most common
human cancers. The top panel plots the incidence data in the
standard log-log style, for which the average slopes are about
5 or 6, corresponding to Armitage and Doll’s model with six
or seven rate-limiting steps. The bottom two panels plot the
same data, showing the slope of the top graph at each point in
time.
The top graph in Figure 1 is the cancer incidence, or rate, and
thus the slope of the rate in the bottom panels is the accel-
eration of cancer incidence at each age. I plotted the prostate
data in a separate panel at the bottom, because the scale differs
from the other cancers. For all four cancers, the acceleration
drops linearly in the later part of life, during which nearly all
cases occur. This observation of a linear decline in acceleration
sets a constraint that any mechanistic model of progression
must be able to explain, just as Armitage and Doll used the
pattern of incidence in response to carcinogens to reject Fisher
and Hollomon’s theory and support Nordling’s idea about
progression.
I do not know the explanation for the steady decline in
acceleration in the latter half of life. However, I did develop a
mathematical extension to Armitage and Doll’s analysis that
suggests a hypothesis about why the decline occurs.4 Briefly,
suppose that n   1 rate-limiting steps must be passed before a
cell lineage is transformed. At birth, one has a large number, N,
of mostly pristine cells. As time passes to midlife, some of the
those N cell lineages have accumulated, for example, m of the
necessary changes for transformation. Those cells have n   1   m
steps remaining, and will be transformed at a rate that increases
with the (n   m)th power of time instead of the nth power of
time that described the transformation rate earlier in life. So,
the hypothesis is that different cell lineages will be passing
various steps independently, and in midlife a person without
cancer will have progressed partway. That could be tested by
high throughput genetic studies of normal cells at different
times of life.
Figure 1 also shows a midlife rise in acceleration for three of the
four cancers. I discuss that elsewhere.4 The point here is that
mathematical models can suggest new hypotheses about
progression. In recent years, such top-down models have played
relatively little role in molecular biology. That limitation probably
occurred because most recent studies have focused on working
out detailed aspects of molecular mechanisms, for which
quantitative theories provide little insight. But now that interest
has shifted to how various mechanisms combine to determine the
behaviour of complex systems, a quantitative perspective such as
the one provided by Armitage and Doll 50 years ago may become
increasingly important for understanding how particular
mechanisms contribute to cancer progression.
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